Search

everythinglearnresearchcommunity

for

Search:↓

The new compound may be a safer alternative to finasteride for prostate protection.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Compound 4 is a promising treatment for hair loss with low toxicity.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Clausena anisata may be effective in treating acne due to its ability to fight bacteria, reduce inflammation, and possibly lower sebum production.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.